Clinical Trial Update: Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials [Phase 2]

View source ↗

Summary

This Phase 2 trial update evaluates safety and antiviral activity of entecavir in chronic hepatitis B patients who previously received entecavir monotherapy in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B Virus, HBV | Phase 2 | Status: COMPLETED | Results posted: 2012-08-23